Monday, September 14, 2020 6:08:38 PM
So that everyone is on the same plane
Isn't that interesting, manufacturing about to change here :?
From SP1 so thanks to him for this. I'll add that Gsk is big on liposomes w/ Operation Warp Speed
https://translate.google.com/translate?hl=en&sl=de&u=https://www.diepresse.com/5861311/teil-des-covid-19-impfstoffes-konnte-aus-osterreich-kommen&prev=search&pto=aue
So I added these
In that, check this out
https://www.fitforhealth.eu/cms/docs/Success_stories/Polymun_success_story.pdf
https://www.polymun.com/about-us/
Aint that interesting
from the Polymun link
Polymun started the development of a biosimilar rhFSH (follicle stimulating hormone) in 2006. Together with our license partner Finox AG, the drug product with the name Bemfola® was clinically tested successfully. Finox AG obtained market approval from EMA in April 2014. Since then, several other countries such as Australia, New Zealand and Israel have granted market approval for Bemfola®. Polymun remains the exclusive manufacturer of rhFSH as drug substance.
https://finoxbiotech.com/
nada much there but
Richter announces the acquisition of Finox Holding for a consideration of CHF190 million
6/30/2016
https://www.richter.hu/en-US/investors/announcements/Pages/extraord160630.aspx
https://www.richter.hu/en-US/our-activity/Pages/Pharmaceutical-manufacturing.aspx
https://www.richter.hu/en-US/richter-group/Pages/default.aspx
She's going to turn folks, release the hounds
Isn't that interesting, manufacturing about to change here :?
From SP1 so thanks to him for this. I'll add that Gsk is big on liposomes w/ Operation Warp Speed
https://translate.google.com/translate?hl=en&sl=de&u=https://www.diepresse.com/5861311/teil-des-covid-19-impfstoffes-konnte-aus-osterreich-kommen&prev=search&pto=aue
So I added these
In that, check this out
https://www.fitforhealth.eu/cms/docs/Success_stories/Polymun_success_story.pdf
https://www.polymun.com/about-us/
Aint that interesting
from the Polymun link
Polymun started the development of a biosimilar rhFSH (follicle stimulating hormone) in 2006. Together with our license partner Finox AG, the drug product with the name Bemfola® was clinically tested successfully. Finox AG obtained market approval from EMA in April 2014. Since then, several other countries such as Australia, New Zealand and Israel have granted market approval for Bemfola®. Polymun remains the exclusive manufacturer of rhFSH as drug substance.
https://finoxbiotech.com/
nada much there but
Richter announces the acquisition of Finox Holding for a consideration of CHF190 million
6/30/2016
https://www.richter.hu/en-US/investors/announcements/Pages/extraord160630.aspx
https://www.richter.hu/en-US/our-activity/Pages/Pharmaceutical-manufacturing.aspx
https://www.richter.hu/en-US/richter-group/Pages/default.aspx
She's going to turn folks, release the hounds
